| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.03. | Quipt Home Medical Corp. - 15-12G, Securities registration termination | - | SEC Filings | ||
| 16.03. | Quipt Home Medical Corp: Quipt completes take-private deal w/ Kingswood, Forager | 1 | Stockwatch | ||
| 16.03. | Stocks in Play: Quipt Home Medical Corp | - | Baystreet.ca | ||
| 16.03. | NSE - Quipt Home Medical Corp. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
| 16.03. | Quipt Home Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.03. | Quipt Home Medical Corp.: Quipt Home Medical Completes the Previously Announced Arrangement With Affiliates of Kingswood and Forager | 320 | GlobeNewswire (Europe) | CINCINNATI, March 16, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company" or "Quipt") (NASDAQ: QIPT; TSX: QIPT)?, a U.S. based home medical equipment provider, focused on end-to-end respiratory... ► Artikel lesen | |
| QUIPT HOME MEDICAL Aktie jetzt für 0€ handeln | |||||
| 06.03. | Quipt Home Medical Corp: Quipt acquisition by Kingswood, Forager okayed by court | 1 | Stockwatch | ||
| 06.03. | Quipt Home Medical Corp.: Quipt Home Medical Receives Final Order Approving Arrangement | 143 | GlobeNewswire (Europe) | CINCINNATI, March 05, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care... ► Artikel lesen | |
| 04.03. | Quipt Home Medical Corp: Quipt Home holders OK acquisition by Kingswood, Forager | 1 | Stockwatch | ||
| 03.03. | Quipt Home Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.03. | Quipt Home Medical Corp.: Quipt Home Medical Announces Voting Results From Special Meeting of Shareholders | 156 | GlobeNewswire (Europe) | CINCINNATI, March 03, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ: QIPT; TSX: QIPT)?, a U.S. based home medical equipment provider, focused on end-to-end respiratory... ► Artikel lesen | |
| 09.02. | Quipt Home Medical Corp. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 04.02. | Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement | 171 | GlobeNewswire (Europe) | CINCINNATI, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory... ► Artikel lesen | |
| 28.01. | Quipt Home Medical Corp. - 10-K/A, Annual Report | 2 | SEC Filings | ||
| 26.01. | Übernahme von Quipt Home Medical erhält kartellrechtliche Freigabe | 1 | Investing.com Deutsch | ||
| 26.01. | Quipt Home Medical Corp. - 8-K, Current Report | 4 | SEC Filings | ||
| 06.01. | Quipt Home Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 19.12.25 | The Quipt Home Medical deal is good for shareholders, Leede says | 1 | Cantech Letter | ||
| 16.12.25 | Quipt Home Medical stock to be acquired by Kingswood and Forager for $3.65 per share | 2 | Investing.com | ||
| 15.12.25 | Quipt Home Medical Corp: Quipt signs deal for acquisition by Kingswood, Forager | 1 | Stockwatch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 39,490 | -0,40 % | Shortseller-Positionen aktuell: u.a. Carl Zeiss Meditec, Evonik, FMC, Gerresheimer, GFT, MTU, Nordex, Ströer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| FAMICORD | 4,740 | +1,07 % | EQS-News: FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung | EQS-News: FamiCord AG
/ Schlagwort(e): 9-Monatszahlen
FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung... ► Artikel lesen | |
| M1 KLINIKEN | 15,060 | 0,00 % | M1 Kliniken schließt Verkauf von Haemato Pharm ab | Die M1 Kliniken AG hat den Verkauf der Haemato Pharm GmbH über ihre Mehrheitsbeteiligung Haemato AG an die Phoenix Group mit Wirkung zum Ablauf des 31. Januar 2026 abgeschlossen. Sämtliche Vollzugsbedingungen... ► Artikel lesen | |
| BAXTER | 15,035 | +0,74 % | Baxter CFO Joel Grade To Leave; Appoints Anita Zielinski As Interim CFO; Reiterates FY26 Outloook | DEERFIELD (dpa-AFX) - Healthcare company Baxter International, Inc. (BAX) announced Monday the departure of executive vice president and chief financial officer (CFO) Joel Grade, who joined... ► Artikel lesen | |
| MEDICLIN | 3,520 | +6,02 % | EQS-HV: MEDICLIN Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 28.05.2026 in Offenburg mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG | EQS-News: MEDICLIN Aktiengesellschaft
/ Bekanntmachung der Einberufung zur Hauptversammlung
MEDICLIN Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am... ► Artikel lesen | |
| DAVITA | 126,20 | -0,47 % | DaVita: The Doctor Will See You Now: The Value of Human Connection in AI-Supported Medicine | As artificial intelligence (AI) continues to take hold across all industries, Adam Weinstein, MD, chief medical information officer for DaVita, highlights how new technological capabilities also help... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,380 | 0,00 % | Co-Diagnostics Reports Full Year 2025 Financial Results | Advancing Global Commercialization Strategy Through CoSara and CoMira Joint Ventures
Progressing Clinical Pipeline and Regulatory Pathways for PCR Platform
Strengthening... ► Artikel lesen | |
| CYTOSORBENTS | 0,505 | +1,81 % | Cytosorbents Corp: CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights | 2025 revenue of $37.1 million, up 4% year-over-year, and 71% Full-year gross margins
Enhanced Balance Sheet Flexibility with an Additional $2.5 million Proceeds... ► Artikel lesen | |
| LIMES SCHLOSSKLINIKEN | 472,00 | 0,00 % | EQS-DD: Limes Schlosskliniken AG: GMF Capital GmbH, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
13.04.2026 / 08:51... ► Artikel lesen | |
| SENSEONICS | 5,750 | 0,00 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen | |
| VIROMED MEDICAL | 5,200 | +0,97 % | EQS-DD: Viromed Medical AG: Heike Perbandt, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.04.2026 / 18:00... ► Artikel lesen | |
| UNIVERSAL HEALTH SERVICES | 154,00 | -0,65 % | Kehoe Law Firm, P.C.: Universal Health Services Investor Alert: Kehoe Law Firm, P.C. Investigating Potential Breach of Fiduciary Duty Claims - UHS | Philadelphia, Pennsylvania--(Newsfile Corp. - March 9, 2026) - Kehoe Law Firm, P.C. is investigating potential breach of fiduciary duty claims on behalf of investors of Universal Health Services... ► Artikel lesen | |
| DELCATH SYSTEMS | 9,032 | -2,06 % | Delcath therapy included in European uveal melanoma guidelines | ||
| NUWELLIS, INC | 1,230 | +2,50 % | Nuwellis, Inc.: Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services |